Neoadjuvant PD-1/PD-L1 Inhibitors for Resectable Head and Neck Cancer: A Systematic Review and Meta-analysis - Masarwy, R; Kampel, L; Horowitz, G; Gutfeld, O; Muhanna, N (JAMA Otolaryngol Head Neck Surg, 2021)